Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 23 Jan 2025

Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis

in Renal Pharmacology

Xiaohui Meng
Li Sheng
Yongqing You
Huibo Dai
Manshu Yu
Funing Wang
Ziren Zhou
Yun Shan
Meixiao Sheng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1515038

159 views

Review

Published on 22 Jan 2025

Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis

in Renal Pharmacology

Xiaoming Li
Rui Xu
Dan Zhang
Ji Cai
He Zhou
Tao Song
Xianyao Wang
Qinghong Kong
Liujin Li
Zhaohui Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1511083

177 views

Editorial

Published on 21 Jan 2025

Editorial: Women in renal pharmacology 2023

in Renal Pharmacology

Nuria Lloberas
Laure Elens
Brenda de winter

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519295

141 views

Original Research

Published on 21 Jan 2025

Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-κB pathway

in Renal Pharmacology

Yan Ye
Xiaopeng Huang
Xueying Li
Fei Gao
Wenzhen Zhong
Anqi Tang
Liangbin Zhao
Dengpiao Xie
Naijing Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1453668

278 views

Original Research

Accepted on 20 Jan 2025

The Neutrophil-to-C3 Ratio: Unveiling Diagnostic Efficacy for Lupus Nephritis and Association with Reduced Retinal Vascular Density in Systemic Lupus Erythematosus

in Renal Pharmacology

Maierhaba Maitiyaer
Peiyi Li
Huangdong Li
Dingwen Jiang
Jingyu Zhang
Chuwei Yang
Xiaobin Yang
Chengmei Chen
Wen Hui Huang
Zhiping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1484320

Review

Accepted on 20 Jan 2025

Nephroprotective effects of substances of medicine food homology and traditional Chinese medicine phytochemicals against acute kidney injury

in Renal Pharmacology

Ling Chen
Yanyan Deng
Jing Hu
Xuezhong Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1539886

Review

Accepted on 16 Jan 2025

Research Progress of Hypoxia-Inducible Factor-1α and Zinc in the Mechanism of Diabetic Kidney Disease

in Renal Pharmacology

Wei Qin
PING NIE
xuejun Hui
fei Chen
xingbao Hu
wenjiao Shi
bing li
Manyu Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1537749

Review

Published on 14 Jan 2025

Current status and prospects of traditional Chinese medicine combined with stem cell therapy for chronic kidney disease

in Renal Pharmacology

Tianyang Qian
Yining He
Chao Han
Ruxue Yan
Weiming He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1505206

241 views

Original Research

Published on 13 Jan 2025

Danshen injection ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibiting ferroptosis via activating SIRT1/GPX4 pathway

in Renal Pharmacology

Yiwen Cao
Huan Zhao
Shuyin Lin
Junqi Chen
Jingli Xiong
Zhijun Zeng
Ziyu Long
Yingru Su
Yingqi Zhong
Lingru Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503628

276 views

Review

Published on 13 Jan 2025

Ferroptosis in kidney disease: a bibliometric analysis from 2012 to 2024

in Renal Pharmacology

Yuxin Hu
Jingyi Tang
Hanzhang Hong
Yexin Chen
Beibei Ye
Ziheng Gao
Gegongming Zhu
Lin Wang
Weijing Liu
Yaoxian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1507574

283 views

Original Research

Accepted on 10 Jan 2025

Impact of Cordyceps Sinensis on Coronary Computed Tomography Angiography Image Quality and Renal Function in a Beagle Model of Renal Impairment

in Renal Pharmacology

Peiji Song
Kun Li
Xiaodie Xu
Guifeng Zhang
Zengkun Wang
Linbing Sun
Zekai Zhao
Ting Li
Ximing Wang
Zhangyong Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1538916

Original Research

Published on 09 Jan 2025

Safety assessment of tolvaptan: real-world adverse event analysis using the FAERS database

in Renal Pharmacology

Peiyang Cao
Qian Wang
Yan Wang
Qing Qiao
Liyuan Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1509310

415 views

Original Research

Published on 07 Jan 2025

Research hotspots and frontiers of endoplasmic reticulum in glomerular podocytes: a bibliometric and visual analysis from 2005 to 2023

in Renal Pharmacology

Wang Junli
Hao Zhihong
Wang Lina
Ou Qiaoqun
Qu Jing
Hu Jiaqi
Shengyou Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488340

320 views

Review

Published on 07 Jan 2025

Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target

in Renal Pharmacology

Yan Li
Yuxin Zhang
Mengxia Cao
Tingting Yuan
Santao Ou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1475198

283 views

Original Research

Published on 07 Jan 2025

High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury

in Renal Pharmacology

Sayantap Datta
Mohammad Atiqur Rahman
Saisudha Koka
Krishna M. Boini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1540639

595 views

Correction

Published on 06 Jan 2025

Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation

in Renal Pharmacology

Guangzhuang Li
Sentao Xian
Xianchao Cheng
Yunhua Hou
Wenqing Jia
Yukui Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1548193

362 views

Navigation group

Articles

Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis

Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis

Editorial: Women in renal pharmacology 2023

Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-κB pathway

The Neutrophil-to-C3 Ratio: Unveiling Diagnostic Efficacy for Lupus Nephritis and Association with Reduced Retinal Vascular Density in Systemic Lupus Erythematosus

Nephroprotective effects of substances of medicine food homology and traditional Chinese medicine phytochemicals against acute kidney injury

Research Progress of Hypoxia-Inducible Factor-1α and Zinc in the Mechanism of Diabetic Kidney Disease

Current status and prospects of traditional Chinese medicine combined with stem cell therapy for chronic kidney disease

Danshen injection ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibiting ferroptosis via activating SIRT1/GPX4 pathway

Ferroptosis in kidney disease: a bibliometric analysis from 2012 to 2024

Impact of Cordyceps Sinensis on Coronary Computed Tomography Angiography Image Quality and Renal Function in a Beagle Model of Renal Impairment

Safety assessment of tolvaptan: real-world adverse event analysis using the FAERS database

Research hotspots and frontiers of endoplasmic reticulum in glomerular podocytes: a bibliometric and visual analysis from 2005 to 2023

Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target

High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury

Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation